We’re excited to announce that our Neurovascular Diseases Working Group (NEUROVASC-WG) has released new Do’s and Don’ts on CADASIL and Moyamoya Angiopathy. These diseases can be challenging to manage, but with the right approach, patients can enjoy a better quality of life.
These Do’s and Don’ts are based on research and clinical experience, and they offer practical recommendations for clinicians treating patients with CADASIL and Moyamoya.
To download the Do’s and Don’ts on CADASIL, click here
To download the Do’s and Don’ts on Moyamoya Angiopathy, click here
We hope that these Do’s and Don’ts will help clinicians provide optimal care for their patients and improve outcomes for those living with CADASIL and Moyamoya.